Coronary Artery Bypass Graft, Coronary Artery Disease and Outcomes

Coronary Artery Bypass Graft

Coronary Artery Disease

Outcomes

Propensity score-based comparison of high-risk coronary artery bypass grafting vs. left ventricular assist device implantation in patients with coronary artery disease and advanced heart failure

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

ObjectivesRevascularization in patients with severely reduced left ventricular function and coronary artery disease (CAD) is associated with a high perioperative risk.

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Coronary Artery Disease Heart Failure Myocardial Infarction

The correlation between severe asymptomatic carotid artery stenosis and severe multi-organ dysfunction after off-pump coronary artery bypass grafting

Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

All enrolled patients underwent carotid artery ultrasound prior to OPCAB. The information was extracted independently by two authors of the study from the medical records.

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Stenosis Coronary Artery Disease Ultrasound

Clinical and functional outcomes associated with pulmonary complications after coronary artery bypass grafting

Journal of Cardiothoracic Surgery

FEBRUARY 13, 2024

Coronary artery bypass grafting(CABG) is a surgical treatment for coronary artery disease aiming at improving symptoms and life expectancy. Despite this, there are pulmonary and functional complications that m.

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Pulmonary Coronary Artery Disease Outcomes

Impact of High Lipoprotein(a) on Long?Term Survival Following Coronary Artery Bypass Grafting

Journal of the American Heart Association

JANUARY 19, 2024

The distribution and prognostic implication of lipoprotein(a) in patients undergoing coronary artery bypass grafting remain unknown. The primary outcome was all‐cause death. The secondary outcome was a composite of major adverse cardiovascular and cerebrovascular events. During a median follow‐up of 3.2

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Coronary Artery Disease Atherosclerosis Risk Factors

Revascularization Strategies in Stable Coronary Artery Disease: ISCHEMIA Trial Insights

Cardiology Update

MARCH 5, 2024

In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronary artery disease. years, with 57.1% occurring within 30 days after CABG. years, with 21.1% occurring within 30 days after PCI.

Coronary Artery Disease

Coronary Artery Disease Ischemia Coronary Artery Bypass Graft Myocardial Infarction

Impact of prior coronary artery bypass grafting and coronary lesion complexity on outcomes of transcatheter aortic valve replacement for severe aortic stenosis

Coronary Artery Disease Journal

MAY 13, 2024

Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. 23), which was not associated with better/worse clinical outcomes in patients with prior CABG.

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Aortic valve Aortic Stenosis

Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis

Heart BMJ

FEBRUARY 12, 2024

Objective Coronary artery bypass grafting (CABG) is an established revascularisation strategy for multivessel and left main coronary artery disease. to 0.80; p=0.008), and no differences on other cardiovascular or bleeding outcomes after CABG.

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Coronary Artery Disease Article Outcomes

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials

Circulation

MARCH 11, 2024

BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Circulation, Ahead of Print.

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Diabetes Coronary Artery Disease Stent

Relationship between uric acid to albumin ratio and saphenous vein graft disease in patients with coronary artery bypass graft

Coronary Artery Disease Journal

MAY 2, 2024

Objective Saphenous vein graft disease (SVGD) remains a challenging issue for patients with coronary artery bypass grafting (CABG). It is associated with poor outcomes and atherosclerosis is the major cause of SVGD. We aim to evaluate the relationship between the SVGD and UAR.

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Angina Atherosclerosis Stenosis

The role of physiology in the contemporary management of coronary artery disease

Heart BMJ

FEBRUARY 23, 2024

Coronary physiology assessment, including epicardial and microvascular investigations, is a fundamental tool in the contemporary management of patients with coronary artery disease. Coronary revascularisation guided by functional evaluation has demonstrated superiority over angiography-only-guided treatment.

Coronary Artery Disease

Coronary Artery Disease Physiology Coronary Artery Bypass Graft Quality of Life

Impact of Diabetes on Outcomes in Left Main Coronary Revascularization: PCI vs. CABG

Cardiology Update

MARCH 25, 2024

Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. Preliminary evidence from trials focusing on patients with multivessel disease has hinted at diabetes as a potential modifier of treatment outcomes. Circulation.

Diabetes

Diabetes Coronary Artery Bypass Graft Outcomes Coronary Artery Disease

Temporal Trend in Revascularization for Patients With Ischemic Cardiomyopathy and Multivessel Coronary Artery Disease

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundCurrent guidelines recommend revascularization in patients with ischemic cardiomyopathy (ICM). Joinpoint regression and multivariable logistic regression analyses were performed to assess the annual percentage change in trends and predictors of the 30‐day mortality rate, respectively.

Coronary Artery Disease

Coronary Artery Disease Coronary Artery Bypass Graft Cardiomyopathy Stenosis

Non-coronary atherosclerosis: a marker of poor prognosis in patients undergoing coronary artery bypass surgery

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

Introduction The presence of non-coronary atherosclerosis (NCA) in patients with coronary artery disease is associated with a poor prognosis. We have studied whether NCA is also a predictor of poorer outcomes in patients undergoing coronary artery bypass grafting (CABG).

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Atherosclerosis Peripheral Arterial Disease Coronary Artery Disease

Abstract 4141539: Impact of Left Ventricular End-Diastolic Diameter on the Prognosis in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Undergoing PCI

Circulation

NOVEMBER 11, 2024

Introduction:Atrial fibrillation (AF) is a common cardiac arrhythmia, the risk of cardiovascular adverse outcome rises when it coexists with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI).

Atrial Fibrillation

Atrial Fibrillation Coronary Artery Bypass Graft Coronary Artery Disease Myocardial Infarction

TIMP-1 in the prognosis of patients who underwent coronary artery bypass surgery: a 12-year follow-up study

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Introduction Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have been linked to clinical outcomes in patients with coronary artery disease (CAD). However, the prognostic value of TIMP-1 in patients with CAD who underwent coronary artery bypass grafting (CABG) has not been elucidated.

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Coronary Artery Disease Myocardial Infarction Cholesterol

Cardiovascular Update

Propensity score-based comparison of high-risk coronary artery bypass grafting vs. left ventricular assist device implantation in patients with coronary artery disease and advanced heart failure

The correlation between severe asymptomatic carotid artery stenosis and severe multi-organ dysfunction after off-pump coronary artery bypass grafting

Clinical and functional outcomes associated with pulmonary complications after coronary artery bypass grafting

Impact of High Lipoprotein(a) on Long?Term Survival Following Coronary Artery Bypass Grafting

Revascularization Strategies in Stable Coronary Artery Disease: ISCHEMIA Trial Insights

Impact of prior coronary artery bypass grafting and coronary lesion complexity on outcomes of transcatheter aortic valve replacement for severe aortic stenosis

Optimal antiplatelet strategy following coronary artery bypass grafting: a meta-analysis

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials

Relationship between uric acid to albumin ratio and saphenous vein graft disease in patients with coronary artery bypass graft

The role of physiology in the contemporary management of coronary artery disease

Impact of Diabetes on Outcomes in Left Main Coronary Revascularization: PCI vs. CABG

Temporal Trend in Revascularization for Patients With Ischemic Cardiomyopathy and Multivessel Coronary Artery Disease

Non-coronary atherosclerosis: a marker of poor prognosis in patients undergoing coronary artery bypass surgery

Abstract 4141539: Impact of Left Ventricular End-Diastolic Diameter on the Prognosis in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Undergoing PCI

TIMP-1 in the prognosis of patients who underwent coronary artery bypass surgery: a 12-year follow-up study

Stay Connected